Document Detail

Markers of acute coronary syndrome in emergency room.
MedLine Citation:
PMID:  18971915     Owner:  NLM     Status:  MEDLINE    
Acute coronary syndromes (ACS) encompasses a spectrum of coronary heart diseases, ranging in severity from unstable angina to ST-elevation myocardial infarction (STEMI). Early diagnosis and risk stratification are needed in order to address correctly hospitalization and treatment. Although the diagnosis of STEMI in the presence of typical electrocardiogram (ECG) changes and symptoms is easy and does not require the use of biomarkers, cardiac biomarkers are particularly important in the Emergency Department (ED), where about 25% of patients admitted are affected by ACS but clinical presentation is often atypical and ECG alterations may be absent. The ideal marker in the ED should have rapid release, high sensitivity and specificity and risk stratifying properties. Classic cardiac biomarkers, like myoglobin, cardiac troponin T or I and creatine kinase-MB, have a poor sensitivity, dependent on the time past from the onset of symptoms to presentation, the duration of ischemia and the amount of myocardial tissue involved. Although the serial testing of these cardiac biomarkers can improve the detection of myocardial necrosis, there is still a need for the development of early markers that can reliably rule out ACS from the ED at presentation and also detect myocardial ischemia in the absence of irreversible myocyte injury. There are several markers which represent the different features of ACS pathogenesis and that can be divided into three major groups: markers of cardiac ischemia and necrosis, markers of inflammation and coronary plaque instability and marker of cardiac function.
V Loria; I Dato; G L De Maria; L M Biasucci
Related Documents :
21299845 - A multicenter, prospective, randomized, controlled trial evaluating the safety and effi...
8980345 - Comparison of cardiac troponin i and lactate dehydrogenase isoenzymes for the late diag...
24618985 - Can the t-peak to t-end interval be a predictor of mortality in patients with st-elevat...
21459275 - Fame comes at a cost: a canadian analysis of procedural costs in use of pressure wire t...
17449875 - Economic analysis of treatments reducing coronary heart disease mortality in england an...
17285225 - Changes in short-term measures of heart rate variability after eight weeks of cardiac r...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Minerva medica     Volume:  99     ISSN:  0026-4806     ISO Abbreviation:  Minerva Med.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-30     Completed Date:  2009-01-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400732     Medline TA:  Minerva Med     Country:  Italy    
Other Details:
Languages:  eng; ita     Pagination:  497-517     Citation Subset:  IM    
Institute of Cardiology, Catholic University, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / diagnosis*
Albumins / analysis
Biological Markers / blood*
C-Reactive Protein / analysis
CD40 Ligand / blood
Emergency Service, Hospital
Fatty Acid-Binding Proteins / blood
Fatty Acids, Nonesterified / blood
Natriuretic Peptide, Brain / blood
Peroxidase / blood
Pregnancy-Associated Plasma Protein-A / analysis
Reg. No./Substance:
0/Albumins; 0/Biological Markers; 0/Fatty Acid-Binding Proteins; 0/Fatty Acids, Nonesterified; 114471-18-0/Natriuretic Peptide, Brain; 147205-72-9/CD40 Ligand; 9007-41-4/C-Reactive Protein; EC; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled c...
Next Document:  Molecular aspects of obesity and related-pathologies